Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mucormycosis.

A M Sugar1

  • 1Evans Memorial Department of Clinical Research, Boston University Medical Center, Massachusetts.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|March 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antifungal combination therapy: where we stand.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2006
Same author

Overview: antifungal combination therapy.

Current opinion in investigational drugs (London, England : 2000)·2002
Same author

Fluconazole in transplant recipients: options and limitations.

Transplant infectious disease : an official journal of the Transplantation Society·2001
Same author

Combined treatment: antifungal drugs with antibodies, cytokines or drugs.

Medical mycology·2001
Same author

Efficacy of voriconazole in treatment of murine pulmonary blastomycosis.

Antimicrobial agents and chemotherapy·2001
Same author

Effect of grapefruit juice on serum voriconazole concentrations in the mouse.

Medical mycology·2000
Same journal

Antibiotic Treatment Duration for Uncomplicated Monomicrobial Enterococcal Bloodstream Infection: A Multicenter Target Trial Emulation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Larger Blood Volume Increases Detection of Fastidious Mycobacteria and Fungi in Blood Culture.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Anticalcitonin: Limited utility of a context-dependent biomarker demonstrated in another real-world data set.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Procalcitonin Testing in Community-Acquired Pneumonia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Wanted: A Relevant Correlate of Protection for Dengue Vaccines.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Safety and Immunogenicity of the Live-Attenuated Quadrivalent Dengue Vaccine V181 Compared With Butantan-DV Among Healthy Adults in Brazil: A Randomized, Double-Blind, Phase 2 Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles

Mucormycosis is a serious fungal infection caused by Mucorales. Aggressive treatment including surgery and amphotericin B improves survival rates for this rare but dangerous disease.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Immunology

Background:

  • Mucormycosis is a severe fungal infection caused by Mucorales, often initiating in the airways.
  • Risk factors include diabetic ketoacidosis, neutropenia, malnutrition, and iron overload, particularly in hemodialysis patients.
  • The immunologic basis for susceptibility remains poorly understood.

Purpose of the Study:

  • To review the clinical presentation, risk factors, and management of mucormycosis.
  • To highlight emerging risk factors and complications.
  • To discuss current and potential treatment strategies.

Main Methods:

  • Literature review of mucormycosis cases and risk factors.
  • Analysis of disease presentation and dissemination patterns.

Related Experiment Videos

  • Evaluation of treatment outcomes and survival rates.

    • Main Results:

    • Primary infection occurs in airways, with potential for sinusitis, rhinocerebral, or pulmonary disease.
    • Dissemination is less common, but direct extension is frequent without aggressive therapy.
    • Hemodialysis patients with iron overload and deferoxamine use are at increased risk.

    Conclusions:

    • Aggressive management, including surgical debridement and intravenous amphotericin B, improves survival.
    • Early recognition and treatment are crucial for managing mucormycosis.
    • Further research is needed to understand underlying immunologic defects and the role of new antifungals.